Skip to main content

Animations

MJFF Publications

8151 - 8160 of 8805 Results
Title
Year
  • Year
  • 2018
  • 2021
  • 2008
  • 2023
  • 2016
  • 2024
  • 2025
  • 2025
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201708184
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcab281
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2008.10.046
    Citation Count: 69
  • Summary Details
    RESTRICTED
    Title: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26600
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035
    Citation Count: 44
  • Summary Details
    OPEN
    Title: PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-07124-4
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: No anti-IgLON5 antibody in carefully diagnosed PSP patients with “atypical” or variant clinical features
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108071
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inhibition or genetic reduction of ASAH1 /acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson’s patients
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddaf166
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: β-adrenoreceptors and the risk of Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Development and Application of High-Throughput Single Cell Lipid Profiling: A Study of SNCA-A53T Human Dopamine Neurons
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2020.101703
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.